Delivery Order SPE2DB20D2014-SPE2DB25FC08D
Award Date 5/30/25
Potential Completion Date 6/2/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Triamterene 50 mg capsules (100-count units) under a firm fixed price contract valued at $3,061.06. The order, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a routine pharmaceutical procurement with no set-aside designation. Performance will be executed from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,347.67 on August 19, 2025, for the supply of Triamterene-HCTZ 75-50 mg tablets in quantities of 500 units. This competitively awarded, firm fixed-price contract is scheduled for completion by August 20, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a Firm Fixed Price Delivery Order contract, SPE2DX15D3017|SPE2DX24F0MNE, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,440.34 contract is for the supply of 4565048086 - TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, with a completion date of July 2, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,952.91, is for the delivery of Triamterene-HCTZ 37.5-25 mg tablets in 500-count bottles. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRIAMTERENE-HCTZ 37.5-25 MG CP 90S, a pharmaceutical product, with a ceiling value of $3,270.73 and a completion date of May 14, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug...
- The Defense Logistics Agency awarded a $133 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 tablets of the prescription medication Triamterene-HCTZ 37.5-25 mg. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by July 20, 2023 in support of the Defense Logistics Agency's logistics and procurement programs. No subcontractors or set aside designations were...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Trokendi XR 50 mg capsules (30-count package) with a ceiling value of $2,832.68. This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. The contract is performed at the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,207.99 to AmerisourceBergen Drug Corp for Triescence 40 mg/ml vials, a pharmaceutical product for military and federal healthcare use. This non-competitive delivery order, issued on August 11, 2025, with completion by August 12, 2025, operates under firm fixed pricing and represents a small-value transaction within the company's broader federal medical supply portfolio. The performance location is listed as Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 2, 2025, for Truqap 200 mg tablets (64-count units) with a ceiling value of $15,514.40. The contract, which is not set-aside and competitively awarded, carries a firm fixed price structure and an ultimate completion date of June 24, 2025. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $2,184.32 firm fixed price delivery order by the Defense Logistics Agency (DLA) on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract covers the supply of Triescence 40 mg/mL vials, a pharmaceutical product supporting federal medical procurement needs. This delivery order was competitively awarded with no set-aside designation and is performed...